Multiple studies have shown that changes in BDNF and proBDNF signaling pathways are present in the development of psychiatric disorders, such as depression [25,26,27], insomnia [28,29], and cognitive impairment [30,31]. Here, BDNF is linked to depressive symptom measurement.